These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11508698)

  • 1. Diadenosine tetraphosphate-gating of recombinant pancreatic ATP-sensitive K(+) channels.
    Jovanovic S; Jovanovic A
    Biosci Rep; 2001 Feb; 21(1):93-9. PubMed ID: 11508698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
    Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
    EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior.
    Alekseev AE; Kennedy ME; Navarro B; Terzic A
    J Membr Biol; 1997 Sep; 159(2):161-8. PubMed ID: 9307442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
    Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y
    Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-26763: ATP-sensitive K+ channel activation and the inhibition of insulin release from human pancreatic beta-cells.
    Cosgrove KE; Straub SG; Barnes PD; Chapman J; Sharp GW; Dunne MJ
    Eur J Pharmacol; 2004 Feb; 486(2):133-9. PubMed ID: 14975702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
    Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
    Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between membrane potential and cytosolic Ca2+ concentration in beta cells from Sur1-/- mice.
    Haspel D; Krippeit-Drews P; Aguilar-Bryan L; Bryan J; Drews G; Düfer M
    Diabetologia; 2005 May; 48(5):913-21. PubMed ID: 15830184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas.
    Geng X; Li L; Watkins S; Robbins PD; Drain P
    Diabetes; 2003 Mar; 52(3):767-76. PubMed ID: 12606519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    Yan FF; Lin CW; Cartier EA; Shyng SL
    Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells.
    Miki T; Nagashima K; Seino S
    J Mol Endocrinol; 1999 Apr; 22(2):113-23. PubMed ID: 10194514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
    Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the insulin-releasing action of alpha-ketoisocaproate and related alpha-keto acid anions.
    Heissig H; Urban KA; Hastedt K; Zünkler BJ; Panten U
    Mol Pharmacol; 2005 Oct; 68(4):1097-105. PubMed ID: 16014804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG; Kinsella JM; Campbell CM; Ashford ML
    Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.